Skip to main content
. 2022 Apr 21;27(5):338–e368. doi: 10.1093/oncolo/oyab065
Number of patients, male 0
Number of patients, female 21
Stage IV
Age Median (range): 55 (38-75) years
Number of prior systemic therapies Median (range): 2(1-3)
Performance Status: ECOG 0 — 6
1 — 12
2 — 3
3 — 0
Unknown — 0